Litigation Details for United States v. Gilead Sciences, Inc. (D. Del. 2019)

✉ Email this page to a colleague

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

The biologic drug covered by the patents cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2022-12-05	370	Exhibit REDACTED Ex A-Z	.S. Patent No. 7,803,788 lists “Gilead Sciences, Inc.” as the assignee. Claim 7 of this patent recites…509 Patent, the ’333 Patent, the ’191 Patent, and the ’423 Patent (collectively, the “Patents-in-Suit… 13 of the ‘509 Patent, claim 13 of the ‘333 Patent, claim 13 of the ’191 Patent, and claim 12 of the…claim 13 of the ’509 Patent, claim 13 of the ’333 Patent, claim 13 of the ’191 Patent, and claim 12 of …from the different patents: ’509 Patent ’333 Patent	External link to document
2023-04-03	422	Exhibit A-I	5,914,331; 5,922,695; 5,935,946; 5,977,089; 6,043,230; 6,057,305; 6,703,396; 7,390,791; 7,803,788…obviousness-type double patenting rejections for the ’333 Patent, the ’191 Patent, and the ’423 Patent, but was … of the ’191 Patent, the ’333 Patent, and the ’423 Patent, the claims of all Patents-in-Suit are …States Patent and Trademark Office. 20. “Patent(s)-in-Suit” refers to U.S. Patent Nos. 9,044,509…license to a patent allegedly comparable to the Patents-in-Suit and any license to a patent relating	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document